TANG CAPITAL PARTNERS LP 13D and 13G filings for TCR2 Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | TCR2 Therapeutics Inc. TCRR | TANG CAPITAL PARTNERS LP | 0 0.000% | -4,215,864 (Position Closed) | Filing |
| 2023-05-05 4:37 pm Purchase | 2023-05-03 | 13G | TCR2 Therapeutics Inc. TCRR | TANG CAPITAL PARTNERS LP | 4,215,864 10.700% | 1,476,917 (+53.92%) | Filing |
| 2023-02-14 4:00 pm Sale | 2022-12-31 | 13G | TCR2 Therapeutics Inc. TCRR | TANG CAPITAL PARTNERS LP | 2,738,947 7.100% | -61,053 (-2.18%) | Filing |
| 2022-03-04 4:00 pm Purchase | 2022-02-22 | 13G | TCR2 Therapeutics Inc. TCRR | TANG CAPITAL PARTNERS LP | 2,800,000 7.300% | 2,800,000 (New Position) | Filing |